In this digital transformation race sprung about by COVID-19, companies like IMAPAC have rapidly increased the use of digital tools to stay afloat during the pandemic. Revamping from having a portfolio that consisted… read more

INFOGRAPHIC OF THE WEEK In a recent market outlook analysis by Genetic Engineering & Biotechnology News, the APAC global cell and gene therapy space has been predicted to emerge as a major market.… read more

IMAPAC recently rounded up its “Corona360 In-Conversation” series of live moderated interviews. It brought together vaccine industry experts in lively, thought-provoking discussions on the challenges and possible solutions in the race to develop… read more

Takeda opens another manufacturing unit to expand its cell therapy product portfolio. Takeda recently opened its 24,000 square-foot cell therapy manufacturing facility in Boston. The facility is expected to produce material through to… read more

Sinovac Biotech To Test It’s COVID-19 Vaccine On Children and Teenagers.  Sinovac Biotech plans to commence a clinical trial of its experimental COVID-19 vaccine on children and teenagers later this month, expanding its… read more

Thermo Fisher’s investments on flexible scalable biologics developments.  Thermo Fisher Scientific has recently opened a new bioprocessing collaboration center adjacent to its biologics manufacturing facility in St Louis, Missouri. Located near the company’s… read more

Market Research is a technique employed to obtain and collate information, leveraging the understandings of the market, in order to improve and tailor products and offerings as per market requirements. This process helps… read more

FDA clears IND application for CAR T-cell therapy for advanced mesothelioma The U.S. Food and Drug Administration recently approved an investigational new drug application for ATA2271, a chimeric antigen receptor T-cell therapy for… read more

AstraZeneca voluntarily pauses clinical trials of its COVID-19 vaccine candidate.  AstraZeneca recently announced that they have voluntarily paused its late-stage global trials of its COVID-19 vaccine candidate due to an unexplained illness in… read more

EV Biologics to Develop a Cell Biologics Incubator Lab EV Biologics recently announced their intentions to build an incubator laboratory for the development of cell and extracellular vesicle (EV) based therapeutics. The lab… read more

Thursday's Thought Leader Spotlight Mr. Shinya Takuma, President, Chugai Pharma Manufacturing, Japan In a past interview with Mr. Shinya Takuma, President at Chugai Pharma Manufacturing Co. in Japan, shares valuable insights into the… read more

INFOGRAPHIC OF THE WEEK The above infographic shows a summary of opportunities in the Cell & Gene Therapy Market in the Asia-Pacific region. Send a request for a customized report : Click Here read more

Precision Biosciences Begins Clinical Trial of CAR T-cell Therapy for Multiple Myeloma. The first patient has already been dosed for Phase 1/2a trial investigating Precision Biosciences‘ new CAR T-cell therapy candidate, PBCAR269A, for… read more